Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS)

By afschroeder • October 10, 2025

Shin AS, Xing Y, Waseem MR, Siwiec R, James-Stevenson T, Rogers N, Bohm M, Wo J, Lockett C, Gupta A, Kadariya J, Toh E, Anderson R, Dong A, Xu H, Gao X. Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS). Sci Rep. 2025 Oct 9;15(1):35375. doi: 10.1038/s41598-025-19363-2. PMID: 41068306; PMCID: PMC12511408.

Tags: Bile acid metabolism, Colonic microflora, Digestive Diseases, Functional gastrointestinal disorder, Gut-brain interaction, microbiome, Publications

Correction: Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients with Steatotic Liver Disease

Greb AC, Kim S, Roney A, Ting PS, Limketkai BN, Chen PH. Correction: Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients with Steatotic Liver[...]

L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial

Gong J, Muranaka H, Choi SY, Tighiouart M, Bhute S, Aja ER, Jacobs JP, Stotland A, Van Eyk J, Elmadbouh OHM, Edderkaoui M, Tanaka S,[...]

Calpeptin Reduces Extracellular Vesicle Secretion and Induces Anti-Inflammatory Effects but Upregulates HO-1 and Alters Adiponectin Levels in Human Adipocytes

Matilainen J, Foster S, Berg V, Tampio J, Turunen T, Mustonen AM, Kyykallio H, Vaittinen M, Männistö V, Pihlajamäki J, Malinen M, Oikari S, Käkelä[...]